ArticleInternational journal of molecular sciences2024

Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.

Zenjiro Sampei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.